Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Adding Dexmedetomidine, Ketamine and Magnesium Sulphate to Caudal Block as Preemptive Analgesia in Hypospadias Repair in Pediatrics: a Randomized Double-blinded Trial

NCT05837000 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT05837000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05837000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Adding Dexmedetomidine, Ketamine and Magnesium Sulphate to Caudal Block as Preemptive Analgesia in Hypospadias Repair in Pediatrics: a Randomized Double-blinded Trial
Lead sponsor
Kafrelsheikh University
Phase
Phase 4
Overall status
Unknown status
Start date
May 15, 2023
Completion date
October 25, 2024
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, hypospadias, ketamine, magnesium sulphate, pediatrics, preemptive analgesia